364 related articles for article (PubMed ID: 16367921)
21. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of the RUNX3 gene in lung cancer.
Sato K; Tomizawa Y; Iijima H; Saito R; Ishizuka T; Nakajima T; Mori M
Oncol Rep; 2006 Jan; 15(1):129-35. PubMed ID: 16328045
[TBL] [Abstract][Full Text] [Related]
23. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
25. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
Kim J; Lee HS; Bae SI; Lee YM; Kim WH
Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
[TBL] [Abstract][Full Text] [Related]
26. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
27. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
30. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
[TBL] [Abstract][Full Text] [Related]
31. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
[TBL] [Abstract][Full Text] [Related]
32. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.
Tsuchiya T; Tamura G; Sato K; Endoh Y; Sakata K; Jin Z; Motoyama T; Usuba O; Kimura W; Nishizuka S; Wilson KT; James SP; Yin J; Fleisher AS; Zou T; Silverberg SG; Kong D; Meltzer SJ
Oncogene; 2000 Jul; 19(32):3642-6. PubMed ID: 10951570
[TBL] [Abstract][Full Text] [Related]
33. Frequent p16 CpG island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway.
Mino A; Onoda N; Yashiro M; Aya M; Fujiwara I; Kubo N; Sawada T; Ohira M; Kato Y; Hirakawa K
Oncol Rep; 2006 Mar; 15(3):615-20. PubMed ID: 16465421
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
35. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
37. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
38. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
[TBL] [Abstract][Full Text] [Related]
39. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
[TBL] [Abstract][Full Text] [Related]
40. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.
Kim SK; Jang HR; Kim JH; Noh SM; Song KS; Kim MR; Kim SY; Yeom YI; Kim NS; Yoo HS; Kim YS
Biochem Biophys Res Commun; 2006 Oct; 349(3):1032-40. PubMed ID: 16959213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
